Expression of soluble Fas and soluble FasL in human nucleus pulposus cells

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 8, 2013, Pages 1567-1573

  Sun, Zhen ^a   Wan, Zhong Yuan ^a   Liu, Zhi Heng ^a   Guo, Yun Shan ^a   Yin, Jun Bin ^b   Duan, Chun Guang ^a   Gao, Yang ^a   Li, Tao ^a   Wang, Hai Qiang ^a   Luo, Zhuo Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immune privilege; Intervertebral disc; Nucleus pulposus; Soluble Fas; Soluble FasL

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE PRIVILEGE; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MALE; METABOLISM; NUCLEUS PULPOSUS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SOLUBLE FAS; SOLUBLE FASL; YOUNG ADULT;

IMMUNE PRIVILEGE; INTERVERTEBRAL DISC; NUCLEUS PULPOSUS; SOLUBLE FAS; SOLUBLE FASL;

ADULT; ANTIGENS, CD95; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; MALE; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84882988080     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mirza SK and White AA 3rd. Anatomy of intervertebral disc and pathophysiology of herniated disc disease. J Clin Laser Med Surg 1995; 13: 131-142.
2. Hughes SP, Freemont AJ, Hukins DW, McGregor AH and Roberts S. The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br 2012; 94: 1298-1304.
3. Peng B, Hao J, Hou S, Wu W, Jiang D, Fu X and Yang Y. Possible pathogenesis of painful intervertebral disc degeneration. Spine (Phila Pa 1976) 2006; 31: 560-566.
4. Geiss A, Larsson K, Rydevik B, Takahashi I and Olmarker K. Autoimmune properties of nucleus pulposus: an experimental study in pigs. Spine (Phila Pa 1976) 2007; 32: 168-173.
5. Sun Z, Zhang M, Zhao XH, Liu ZH, Gao Y, Samartzis D, Wang HQ and Luo ZJ. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol 2013; 6: 1009-1014.
6. Griffith TS, Brunner T, Fletcher SM, Green DR and Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
7. Record Owner NLM. A role for CD95 ligand in preventing graft rejection.
8. Chowdhury I, Tharakan B and Bhat GK. Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 2006; 11: 506-525.
9. Suda T, Takahashi T, Golstein P and Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
10. Takada T, Nishida K, Doita M and Kurosaka M. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine (Phila Pa 1976) 2002; 27: 1526-1530.
11. Park JB, Kim KW, Han CW and Chang H. Expression of Fas receptor on disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 2001; 26: 142-146.
12. Kaneyama S, Nishida K, Takada T, Suzuki T, Shimomura T, Maeno K, Kurosaka M and Doita M. Fas ligand expression on human nucleus pulposus cells decreases with disc degeneration processes. J Orthop Sci 2008; 13: 130-135.
13. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ and Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
14. Tanaka M, Itai T, Adachi M and Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998; 4: 31-36.
15. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J and Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 2001; 26: 1873-1878.
16. Wang J, Tang T, Yang H, Yao X, Chen L, Liu W and Li T. The expression of Fas ligand on normal and stabbed-disc cells in a rabbit model of intervertebral disc degeneration: a possible pathogenesis. J Neurosurg Spine 2007; 6: 425-430.
17. Yamamoto J, Maeno K, Takada T, Kakutani K, Yurube T, Zhang Z, Hirata H, Kurakawa T, Sakai D, Mochida J, Doita M, Kurosaka M and Nishida K. Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells. J Orthop Res 2013; 31: 608-615.
18. Park JB, Lee JK, Cho ST, Park EY and Riew KD. A biochemical mechanism for resistance of intervertebral discs to metastatic cancer: Fas ligand produced by disc cells induces apoptotic cell death of cancer cells. Eur Spine J 2007; 16: 1319-1324.
19. Ulukaya E, Acilan C, Yilmaz M, Yilmaztepe-Oral A, Ari F, Zik B, Ursavas A and Tokullugil AH. sFas levels increase in response to cisplatin-based chemotherapy in lung cancer patients. Cell Biochem Funct 2010; 28: 565-570.
20. Murata J and Abe R. Soluble Fas ligand: is it a critical mediator of toxic epidermal necrolysis and Stevens-Johnson syndrome? J Invest Dermatol 2007; 127: 744-745.
21. Fersching DM, Nagel D, Siegele B, Salat C, Heinemann V, Holdenrieder S and Stoetzer OJ. Apoptosis-related biomarkers sFAS, MIF, ICAM-1 and PAI-1 in serum of breast cancer patients undergoing neoadjuvant chemotherapy. Anticancer Res 2012; 32: 2047-2058.
22. Vysotskii MM, Digaeva MA, Kushlinskii NE, Abbasova SG, Laktionov KP, Ermilova VD, Bakhoeva KA, Kryuk YV and Manukhin IB. Serum sFas, leptin, and VEGF in patients with ovarian cancer and benign tumors. Bull Exp Biol Med 2009; 148: 810-814.
23. Tanaka M, Suda T, Takahashi T and Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-1135.
24. Han D, Ding Y, Liu SL, Wang G, Si IC, Wang X, Cui L and Huang D. Double role of Fas ligand in the apoptosis of intervertebral disc cells in vitro. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 938-947.
25. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S and Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998; 4: 1287-1292.